Seeing Is Believing
Analyst Chris Cooper, currently employed at GOLDMAN SACHS,
Most recent stock forecast was given on RMD, ResMed at 02-Nov-2025.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$300
$53.12 (21.52%)
$270
2 days ago
(31-Oct-2025)
14/15 (93.33%)
$53.12 (21.52%)
98
Buy
$304
$57.12 (23.14%)
$219
12 days ago
(21-Oct-2025)
6/7 (85.71%)
$35.78 (13.34%)
73
Buy
$330
$83.12 (33.67%)
$285
1 months 15 days ago
(18-Sep-2025)
7/8 (87.5%)
$56.71 (20.75%)
38
Buy
$290
$43.12 (17.47%)
6 months 9 days ago
(24-Apr-2025)
17/17 (100%)
$54.9 (23.35%)
363
Hold
$248
$1.12 (0.45%)
$260
6 months 9 days ago
(24-Apr-2025)
3/3 (100%)
$12.9 (5.49%)
70